Skip to content

13F-HR filed by RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 32 holding rows worth $1,678,386,000.

Accession
0001104659-19-064263
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 32 entries on the cover page, a total value of $1,678,386,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,678,386,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR4,132,442$398,037,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,775,207$159,625,000thousands by filing date
SYNTHORX INC COM87167A103Stock9,724,598$158,219,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM4,858,260$114,898,000thousands by filing date
ZOGENIX INC.98978L204Common Stock2,260,751$90,520,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock2,162,671$77,791,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM3,422,312$73,888,000thousands by filing date
SATSUMA PHARMACEUTICALS INC80405P107COM4,681,858$70,275,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR5,224,475$62,067,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock4,571,164$47,266,000thousands by filing date
RETROPHIN INC761299106COM3,987,560$46,216,000thousands by filing date
PREVAIL THERAPEUTICS INC74140Y101COM3,363,605$41,305,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock6,880,323$38,633,000thousands by filing date
ARVINAS INC04335A105COM1,663,512$35,849,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM2,456,669$35,278,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO6,166,875$32,068,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock1,875,209$28,203,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM1,119,963$24,068,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM3,247,005$19,060,000thousands by filing date
KALA BIO INC COM483119103Stock4,537,478$17,265,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM1,842,366$15,457,000thousands by filing date
KODIAK SCIENCES INC50015M109COM1,025,165$14,742,000thousands by filing date
ALECTOR INC014442107COMMON STOCK1,000,000$14,420,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock664,385$13,447,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock429,399$11,516,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW2,365,912$8,458,000thousands by filing date
IGM BIOSCIENCES INC449585108COM466,368$8,278,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM478,107$6,077,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM200,000$5,206,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,782,202$4,188,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW1,000,000$3,370,000thousands by filing date
SENSEONICS HLDGS INC81727U105COM2,727,273$2,696,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-19-064263this filing2019-11-14acceptance time not in the bulk data set